Afatinib in Advanced NRG1-Rearranged Malignancies
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04410653 |
Recruitment Status :
Not yet recruiting
First Posted : June 1, 2020
Last Update Posted : April 13, 2021
|
Sponsor:
German Cancer Research Center
Collaborator:
German Consortium for Translational Cancer Research
Information provided by (Responsible Party):
German Cancer Research Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Not yet recruiting |
---|---|
Estimated Primary Completion Date : | December 1, 2023 |
Estimated Study Completion Date : | December 1, 2023 |